User:Mattsnod/sandbox: Difference between revisions
Content deleted Content added
mNo edit summary |
mNo edit summary |
||
| Line 5: | Line 5: | ||
| traded_as = {{NASDAQ|SYNH}} |
| traded_as = {{NASDAQ|SYNH}} |
||
| industry = [[Contract Research Organization]], [[Pharmaceutical]] Service Consulting, [[Public Relations]], [[Biopharmaceutical]], [[Advertising]], [[Marketing]] |
| industry = [[Contract Research Organization]], [[Pharmaceutical]] Service Consulting, [[Public Relations]], [[Biopharmaceutical]], [[Advertising]], [[Marketing]] |
||
| foundation = {{Start date|2018}}<ref>{{Cite web|date=4 January 2018|title=INC Research/inVentiv Health Becomes Syneos Health|url=https://globenewswire.com/news-release/2018/01/04/1283447/0/en/INC-Research-inVentiv-Health-Becomes-Syneos-Health.html|publisher=GlobeNewswire}}</ref> |
| foundation = {{Start date|2018}}<ref name="INC/INH Syneos">{{Cite web|date=4 January 2018|title=INC Research/inVentiv Health Becomes Syneos Health|url=https://globenewswire.com/news-release/2018/01/04/1283447/0/en/INC-Research-inVentiv-Health-Becomes-Syneos-Health.html|publisher=GlobeNewswire}}</ref> |
||
(inVentiv Health: 1999) |
(inVentiv Health: 1999) |
||
| Line 18: | Line 18: | ||
| Areas served = Worldwide |
| Areas served = Worldwide |
||
}} |
}} |
||
'''Syneos Health''' is a global contract research organization (CRO) and contract commercialization organization (CCO) headquartered in Raleigh, North Carolina<ref name="10-K">{{Cite web|url=http://www.investor.syneoshealth.com/static-files/9469ea8d-86d3-4e05-a98d-30e5d347d8b8|title=Syneos Health SEC Form 10-K|date=31 December 2018|website=Syneos Health}}</ref>. The company, created through the merger of INC Research and inVentiv Health, on August 1, 2018<ref |
'''Syneos Health''' is a global contract research organization (CRO) and contract commercialization organization (CCO) headquartered in Raleigh, North Carolina<ref name="10-K">{{Cite web|url=http://www.investor.syneoshealth.com/static-files/9469ea8d-86d3-4e05-a98d-30e5d347d8b8|title=Syneos Health SEC Form 10-K|date=31 December 2018|website=Syneos Health}}</ref>. The company, created through the merger of INC Research and inVentiv Health, on August 1, 2018<ref name="INC/INH Syneos"/> has more than 21,000 employees and provides services in more than 110 countries<ref name="10-K"/>. |
||
The company provides clinical development and commercial solution offerings to biopharmaceutical customers – spanning from phase I-IV clinical development services, functional service clinical development services to public relations, advertising, market access solutions and consulting services. |
The company provides clinical development and commercial solution offerings to biopharmaceutical customers – spanning from phase I-IV clinical development services, functional service clinical development services to public relations, advertising, market access solutions and consulting services. |
||
Revision as of 05:18, 16 August 2018
| Company type | Public |
|---|---|
| Nasdaq: SYNH | |
| Industry | Contract Research Organization, Pharmaceutical Service Consulting, Public Relations, Biopharmaceutical, Advertising, Marketing |
| Founded | 2018[1]
(inVentiv Health: 1999) (INC Research: 1998) |
| Headquarters | Raleigh, North Carolina[2] |
Key people | Alistair Macdonald, CEO[2] |
Number of employees | 21,000[2] |
| Website | syneoshealth |
Syneos Health is a global contract research organization (CRO) and contract commercialization organization (CCO) headquartered in Raleigh, North Carolina[2]. The company, created through the merger of INC Research and inVentiv Health, on August 1, 2018[1] has more than 21,000 employees and provides services in more than 110 countries[2].
The company provides clinical development and commercial solution offerings to biopharmaceutical customers – spanning from phase I-IV clinical development services, functional service clinical development services to public relations, advertising, market access solutions and consulting services.
References
- ^ a b "INC Research/inVentiv Health Becomes Syneos Health". GlobeNewswire. 4 January 2018.
- ^ a b c d e "Syneos Health SEC Form 10-K". Syneos Health. 31 December 2018.